NAPEPLD

mutation — cross-omics
Cross-omicsMUTATION → PROTEIN-RPPAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, NAPEPLD mutation is significantly associated with the total protein of many other genes, with 32 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible NAPEPLD-associated genes across cancer lineages are GSK-3_pS9, p38-MAPK_pT180_Y182, and PDCD4. Each is linked with NAPEPLD in more than 1 cancer types. Because this analysis shows association rather than direction, both NAPEPLD-to-partner and partner-to-NAPEPLD results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, GSK-3_pS9 grouped by NAPEPLD-low versus NAPEPLD-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NAPEPLD→partner) and Y-score (partner→NAPEPLD) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECGSK-3_pS9 →-0.367-1.584.011.01932
UCECp38-MAPK_pT180_Y182 →-0.451-1.912.005.00532
UCECPDCD4 →-0.613-2.990<.001<.00132
UCECPKC-b-II_pS660 →-0.338-2.807<.001<.00132
UCECTFRC →+0.417+1.584.029.01932
UCECASNS →+0.465+2.000<.001.02932
Each partner links to its Q-omics profile. Showing the 6 strongest of 32 associations by consensus.

GSK-3_pS9 by NAPEPLD expression — UCEC

Box plot of GSK-3_pS9 in NAPEPLD-low vs NAPEPLD-high samples in UCEC.

Explore this box plot interactively →

Exploration